🩺 Subcutaneous Insulin Administration

Subcutaneous insulin administration is a fundamental skill for managing glucose levels in diabetic patients. It involves depositing insulin into the fatty tissue layer just beneath the skin to ensure slow, predictable absorption. Proper technique is vital to prevent complications such as lipohypertrophy and to ensure optimal glycaemic control. Practitioners must be proficient in pen device priming, site selection, and patient education regarding self-administration and sharps safety.

Subcutaneous insulin is indicated for the management of Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (when oral hypoglycaemics are insufficient or contraindicated), and Gestational Diabetes. It is also used for the temporary management of hyperglycaemia during acute illness or perioperatively in patients normally managed with non-insulin therapies. Administration is primarily used to replicate basal and bolus insulin patterns to maintain euglycaemia.

There are no absolute contraindications to insulin administration if required for glycaemic control, but specific sites should be avoided if they show signs of infection, inflammation, scarring, or significant lipohypertrophy. Use with caution in patients with needle phobia or those unable to safely manage sharps disposal. Alternative routes (IV) are required in states of severe metabolic derangement like Diabetic Ketoacidosis (DKA) where peripheral perfusion may be compromised.

Required items include clean non-sterile gloves, the prescribed insulin (pen device or syringe/vial), a compatible sterile fine-gauge needle (typically 4mm to 6mm), an alcohol-free skin cleanser if required, a gauze swab, and a yellow sharps bin. The patient’s insulin prescription chart must be checked against their identification band. Blood glucose monitoring equipment should be available to confirm the current requirement.

Begin by confirming the patient's identity and checking the prescription chart for the correct type and dose of insulin. Wash hands and don gloves. Select an appropriate injection site and inspect for lumps or bruising. If using a pen, prime it by performing a 2-unit 'air shot' into the air until insulin is seen. Dial the prescribed dose. Gently stretch the skin and insert the needle at a 90-degree angle into the subcutaneous tissue. Depress the plunger fully and hold for 10 seconds to ensure the full dose is delivered. Withdraw the needle directly, dispose of it immediately in the sharps bin, and do not massage the site.

Interpretation focuses on the clinical response rather than the technique itself. Follow-up blood glucose monitoring (usually 1-2 hours post-bolus) is essential to assess the efficacy of the dose. The injection site should be inspected regularly for lipohypertrophy (rubbery swellings) or lipoatrophy. If blood glucose remains high despite correct technique, review the dose or the timing of administration relative to meals. Persistent hypoglycaemia may indicate the need for a dose reduction or change in carbohydrate intake.

Common pitfalls include failing to rotate injection sites leading to lipohypertrophy, which significantly impairs insulin absorption. Students often forget to prime the needle with two units of insulin (the 'air shot') to ensure patency and remove air bubbles. Injecting into muscle rather than subcutaneous fat or cleaning the skin with an alcohol swab (which can toughen the skin and cause stinging) are also frequent errors. Furthermore, failing to hold the needle in place for the full 10 seconds post-injection can result in drug leakage and under-dosing.

Always check the expiry date and the type of insulin against the prescription chart in front of the examiner. Demonstrate the 'air shot' clearly, priming with 2 units until a drop appears at the needle tip. Pinched skin technique is generally only required in very thin patients or if using needles longer than 8mm; otherwise, inject at a 90-degree angle. Verbally state that you would rotate the site from the previous injection. Hold the needle in for a slow count of ten before withdrawing.

Relates to MLA content map item 'Diabetes Mellitus'. Students must demonstrate competence in patient education regarding site rotation (abdomen, thighs, buttocks) and the risks of lipohypertrophy and hypoglycaemia. Awareness of the DVLA regulations regarding insulin-treated diabetes and driving is essential for final-year assessments. Knowledge of the differences between rapid-acting, biphasic, and long-acting analogues is expected.